Results 251 to 260 of about 1,072,475 (388)

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad   +9 more
wiley   +1 more source

Corin in Natriuretic Peptide Processing and Hypertension

open access: yesCurrent Hypertension Reports, 2014
Yiqing Zhou, Qingyu Wu
semanticscholar   +1 more source

Inhibiting atrial natriuretic peptide clearance reduces myocardial fibrosis and improves cardiac function in diabetic rats. [PDF]

open access: yesEur Heart J Open
Bakhos JJ   +11 more
europepmc   +1 more source

Atrial natriuretic peptide concentrations in pre-eclampsia:: Authors' reply [PDF]

open access: green, 1987
J. K. Thomsen   +4 more
openalex   +1 more source

Atrial natiuretic peptid in normal humans: Hemodynamic and renal effects after single and repeated bolus injection [PDF]

open access: yes, 1989
Ball, P.   +8 more
core  

The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis.

open access: yesJournal of the American College of Cardiology, 2014
R. Rodseth   +26 more
semanticscholar   +1 more source

Mono and combination therapies in pulmonary arterial hypertension patients with comorbidities: A COMPERA analysis

open access: yesESC Heart Failure, EarlyView.
AIM This analysis provides a comparison of the efficacy of initial mono and combination therapy in patients with PAH and cardiovascular comorbidities or with risk factors of HFpEF (heart failure with preserved ejection fractioin).METHOD Data from the European COMPERA registry were used for a matched pair analysis.
Dirk Skowasch   +20 more
wiley   +1 more source

Electron microscopic findings predict clinical outcomes in patients with non‐ischaemic cardiomyopathy

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Electron microscopy reveals microstructural alterations in cardiomyocyte nuclei and myofilaments in non‐ischaemic cardiomyopathy (NICM), particularly in dilated cardiomyopathy (DCM). Nevertheless, the correlation between such observations and clinical outcomes, including prognosis and left ventricular reverse remodelling (LVRR), remains ...
Rie Higuchi   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy